News
WANECAM-2 consortium reports positive results from phase 2b study of novel treatment for children with malaria
Today, the West African Network for Clinical Trials of Antimalarial Drugs (WANECAM-2) consortium has announced positive results from the phase 2b KALUMI study of the…
Save the date! 15-20 June 2025: Twelfth EDCTP Forum
We are delighted to announce that the Twelfth EDCTP Forum will take place on 15-20 June 2025, at the Kigali Convention Centre in Kigali, Rwanda.…
Eswatini joins EDCTP Association
EDCTP is pleased to welcome Eswatini on board as the newest member country of the EDCTP Association, bringing the total number of African countries to…
EDCTP Annual Report 2023: two decades and beyond
Twenty years since its launch, the EDCTP programmes have established a model for how equitable research partnerships should operate. This ‘partnership of equals’ covers both…
World Malaria Day 2024: Accelerating the development of innovative approaches to end malaria
On this World Malaria Day, under the theme ‘Accelerating the fight against malaria for a more equitable world’ we are reminded that more than 90%…
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Positive data from the phase II/III CALINA study, part of the EDCTP-funded PAMAfrica consortium, demonstrated that a novel formulation of Coartem® (artemether-lumefantrine) developed for babies…
World TB Day 2024: Funding innovative research to end TB
On this World TB Day 2024, EDCTP reinforces its commitment to investing in tuberculosis (TB) research and development, an important part of the jigsaw to…
An innovative and integrated intervention package delivered through the health system could protect infants from HIV
Paediatric HIV infections remain unacceptably high, with UNAIDS estimating 130,000 new cases in 2022, most of which occur during breastfeeding. The widespread implementation of universal…
International Women’s Day 2024: Investing in women to accelerate progress
This year on International Women’s Day, EDCTP joins the global health community in celebrating diversity and empowerment and underscores its commitment to investing in women…
World NTD Day 2024: investing to control and eliminate neglected tropical diseases
Global investment into research and development of new products for neglected tropical diseases (NTDs, also known as neglected infectious diseases) is limited and there is…
African women living with HIV have an effective option to prevent malaria during pregnancy
The combination of two antimalarial drugs (DHA-PPQ) reduces the risk of malaria infection and disease in pregnant women on HIV treatment, according to results from…
2023 End of the year message from Mr Abdoulie Barry, Acting Executive Director
Dear Colleagues, Partners and Friends, As we look forward to celebrating Christmas and New Year with our families and friends, it is important to highlight…
Early data shows that the H56:IC31 candidate vaccine did not provide protection against TB recurrence
The Statens Serum Institut (SSI) announced today that they will stop the development of the H56:IC31 tuberculosis (TB) candidate vaccine. The first analyses of data…
EMA recommends arpraziquantel for treatment of schistosomiasis in preschool-aged children
Today, the Pediatric Praziquantel Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive…
EMA gives positive opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of the use of Fexinidazole Winthrop…